ENACT: A Study of ENX-101 as Adjunctive Treatment in Patients With Focal Seizures
Condition: Focal Epilepsy · Sponsor: Engrail Therapeutics INC
About this study
The ENACT trial is designed to evaluate the efficacy and safety of ENX-101 administered adjunctively to current therapy in reducing seizure frequency in patients diagnosed with focal (partial onset) epilepsy and treated with 1 to 4 antiseizure medications yet still experiencing seizures.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (38)
| Barrow Neurological Institute | Phoenix, Arizona, United States | — |
| University of Arizona | Tucson, Arizona, United States | — |
| Rancho Research Institute at Rancho Los Amigos National Rehabilitation Center | Downey, California, United States | — |
| University of Colorado | Aurora, Colorado, United States | — |
| University of Florida Research Institute of Orlando | Gainesville, Florida, United States | — |
| Royal Care Medical Research Corporation | Miami, Florida, United States | — |
| University of Miami | Miami, Florida, United States | — |
| D&H National Research Centers | Miami, Florida, United States | — |
| S&G Research Center Corp. | Miami, Florida, United States | — |
| Florida Hospital | Orlando, Florida, United States | — |
| Comprehensive Neurology Clinic | Orlando, Florida, United States | — |
| Emory University School of Medicine | Atlanta, Georgia, United States | — |
+ 26 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05481905